Structural studies of the protein endostatin in fusion with BAX BH3 death domain, a hybrid that presents enhanced antitumoral activity-Reference-Cited by-同舟云学术

Structural studies of the protein endostatin in fusion with BAX BH3 death domain, a hybrid that presents enhanced antitumoral activity

Published:2016-09-23 Issue:3 Volume:64 Page:356-363
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Chura-Chambi Rosa Maria¹,Arcuri Helen Andrade²,Lino Felipe¹,Versati Natan¹,Palma Mario Sergio³,Favaro Denize C.⁴,Morganti Ligia¹

Affiliation:

1. Centro de Biotecnologia; Instituto de Pesquisas Energéticas e Nucleares; IPEN-CNEN/SP; São Paulo Brazil

2. Departamento de Imunologia Clínica e Alergia da Faculdade de Medicina da USP; São Paulo Brazil

3. Centro de Estudos de Insetos Sociais; Instituto de Biociências de Rio Claro; UNESP; Rio Claro São Paulo Brazil

4. Departamento de Química; Instituto de Ciências Exatas; Universidade Federal de Minas Gerais; Belo Horizonte Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Reference40 articles.

1. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

2. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

3. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

4. Clinical translation of angiogenesis inhibitors

5. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth